ArticlePharmaceuticals (Basel, Switzerland)2022

Real-World Analysis of Nivolumab and Atezolizumab Efficacy in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer.

Miriam Alonso-García et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.